SE7704616L - Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat - Google Patents
Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivatInfo
- Publication number
- SE7704616L SE7704616L SE7704616A SE7704616A SE7704616L SE 7704616 L SE7704616 L SE 7704616L SE 7704616 A SE7704616 A SE 7704616A SE 7704616 A SE7704616 A SE 7704616A SE 7704616 L SE7704616 L SE 7704616L
- Authority
- SE
- Sweden
- Prior art keywords
- group
- desoxy
- prostaglandin
- derivatives
- way
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 150000001342 alkaline earth metals Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000002585 base Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7612942A FR2349328A1 (fr) | 1976-04-30 | 1976-04-30 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
FR7701299A FR2377395A2 (fr) | 1977-01-18 | 1977-01-18 | Nouveaux derives de la 11-desoxy prostaglandine f2, leur procede de preparation et leur application comme medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7704616L true SE7704616L (sv) | 1977-10-31 |
SE436037B SE436037B (sv) | 1984-11-05 |
Family
ID=26219428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7704616A SE436037B (sv) | 1976-04-30 | 1977-04-21 | Sett att framstella nya 11-desoxi-prostaglandin-f?712-derivat |
Country Status (14)
Country | Link |
---|---|
US (1) | US4119727A (sv) |
JP (1) | JPS52148048A (sv) |
AR (1) | AR222627A1 (sv) |
AT (1) | AT355739B (sv) |
AU (1) | AU511408B2 (sv) |
CA (1) | CA1100493A (sv) |
CH (1) | CH620675A5 (sv) |
DE (1) | DE2719244A1 (sv) |
DK (1) | DK187677A (sv) |
GB (1) | GB1538842A (sv) |
IE (1) | IE45141B1 (sv) |
LU (1) | LU77240A1 (sv) |
NL (1) | NL7704758A (sv) |
SE (1) | SE436037B (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0282901U (sv) * | 1988-12-12 | 1990-06-27 | ||
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
AR047894A1 (es) | 2004-02-25 | 2006-03-01 | Wyeth Corp | Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b |
WO2005081960A2 (en) * | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
US7183310B2 (en) | 2004-08-10 | 2007-02-27 | Allergan, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7101904B2 (en) * | 2004-08-10 | 2006-09-05 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
US7906552B2 (en) | 2004-08-10 | 2011-03-15 | Allergan, Inc. | Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
NZ555945A (en) * | 2005-01-14 | 2011-01-28 | Allergan Inc | Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
DE602006018583D1 (de) * | 2005-03-04 | 2011-01-13 | Sucampo Ag | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten |
AU2006311942B2 (en) | 2005-11-03 | 2012-11-22 | Allergan, Inc. | Prostaglandins and analogues as agents for lowering intraocular pressure |
EP2291346A2 (en) * | 2008-05-15 | 2011-03-09 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
US9695254B2 (en) | 2012-11-26 | 2017-07-04 | Braskem S.A. | Metallocene catalyst supported by hybrid supporting means, process for producing same, polymerization process for producing an ethylene homopolymer or copolymer with broad or bimodal molar mass distribution, use of the supported metallocene catalyst and ethylene polymer with broad or bimodal molar mass distribution |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3776940A (en) * | 1966-08-09 | 1973-12-04 | G Just | Intermediates for producing prostaglandins |
US3956284A (en) * | 1972-07-13 | 1976-05-11 | Pfizer Inc. | Heterocyclic 15-substituted-ω-pentanorprostoglandins |
US3794664A (en) * | 1972-08-17 | 1974-02-26 | G Just | Bicyclo(3.1.0)hexane intermediates for producing prostaglandins f1alpha and f1beta |
US4387241A (en) * | 1974-11-01 | 1983-06-07 | American Cyanamid Company | Novel 16-aryloxy-17,18,19,20-tetranorprostanoic acids and derivatives |
-
1977
- 1977-04-21 SE SE7704616A patent/SE436037B/sv not_active IP Right Cessation
- 1977-04-29 GB GB18082/77A patent/GB1538842A/en not_active Expired
- 1977-04-29 AR AR267416A patent/AR222627A1/es active
- 1977-04-29 CH CH541177A patent/CH620675A5/fr not_active IP Right Cessation
- 1977-04-29 DE DE19772719244 patent/DE2719244A1/de active Granted
- 1977-04-29 NL NL7704758A patent/NL7704758A/xx not_active Application Discontinuation
- 1977-04-29 CA CA277,423A patent/CA1100493A/fr not_active Expired
- 1977-04-29 DK DK187677A patent/DK187677A/da not_active Application Discontinuation
- 1977-04-30 JP JP5061277A patent/JPS52148048A/ja active Granted
- 1977-05-02 IE IE885/77A patent/IE45141B1/en unknown
- 1977-05-02 US US05/792,563 patent/US4119727A/en not_active Expired - Lifetime
- 1977-05-02 AU AU24795/77A patent/AU511408B2/en not_active Expired
- 1977-05-02 AT AT310177A patent/AT355739B/de not_active IP Right Cessation
- 1977-05-03 LU LU77240A patent/LU77240A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AR222627A1 (es) | 1981-06-15 |
AU2479577A (en) | 1978-11-09 |
AU511408B2 (en) | 1980-08-21 |
DE2719244A1 (de) | 1977-11-17 |
DK187677A (da) | 1977-10-31 |
JPS52148048A (en) | 1977-12-08 |
IE45141B1 (en) | 1982-06-30 |
NL7704758A (nl) | 1977-11-01 |
SE436037B (sv) | 1984-11-05 |
LU77240A1 (sv) | 1977-12-13 |
US4119727A (en) | 1978-10-10 |
GB1538842A (en) | 1979-01-24 |
CH620675A5 (sv) | 1980-12-15 |
IE45141L (en) | 1977-10-30 |
ATA310177A (de) | 1979-08-15 |
DE2719244C2 (sv) | 1987-10-15 |
AT355739B (de) | 1980-03-25 |
JPS6131103B2 (sv) | 1986-07-17 |
CA1100493A (fr) | 1981-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8401134D0 (sv) | Forfarande for framstellning av dihydro-cyklosporin d | |
ES477695A1 (es) | Un procedimiento para preparar derivados de deshidrociclici-minoacidos. | |
SE8104132L (sv) | Mjuka steroider med antiiflammatorisk verkan | |
SE8003815L (sv) | Alkyl-ketohexopyranosid-derivat | |
SE7704616L (sv) | Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat | |
SE7707341L (sv) | 4-hydroxifenylalkanolamin-derivat och forfarande for framstellning derav | |
SE7602144L (sv) | Kvaternera imidazoliumforeningar | |
SE7710873L (sv) | Nya 1h-pyrazolo(3,4-b)pyridiner | |
ES555007A0 (es) | Procedimiento para preparar compuestos de 5-alquil-1-fenil-2-piperazinoalquilpirazolin-3-ona. | |
FI830893L (fi) | Nya fenylpiperazin-derivat samt deras framstaellningsfoerfarande | |
SE7713704L (sv) | Propionsyraderivat och sett for framstellning av desamma | |
ES377662A1 (es) | Procedimiento para la preparacion de nuevos compuestos de derivados de dialcohil-xantina. | |
SE8006953L (sv) | Heterocykliska foreningar | |
SE7607088L (sv) | 5-fluor-uracilderivat. | |
ES468127A1 (es) | Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina | |
GB2005246A (en) | beta -Lactam compounds and processes for their preparation | |
SE7812371L (sv) | Forfarande for framstellning av fenoxialkanolaminderivat | |
ES447751A1 (es) | Procedimiento para preparar derivados de imidazolilquinazo- lina. | |
ES540260A0 (es) | Procedimiento para preparar derivados de 2-alcoxiaminosulfo-nilbencenosulfonilurea | |
ES471267A1 (es) | Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos | |
GB2003866A (en) | Thiourea derivatives | |
SE7509069L (sv) | Forfarande for framstellning av cyklopropylmetylamin-derivat. | |
ES460297A1 (es) | Un compuesto. | |
SE7901316L (sv) | Derivat av dehydrocykliciminsyror | |
ES458092A1 (es) | Procedimiento para la obtencion de derivados de la n1, n4- dioxo-quinoxalina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7704616-7 Effective date: 19910117 Format of ref document f/p: F |